Brevibloc Injection
Product Images NDC 10019-666
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brevibloc (NDC 10019-666). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Two-port Intravia Bag (Image 01)
Representative Brevibloc 10mg Premier Pro Container Label 10019-670-10 (Image 03)
This is a description of a medication called Breviblog Premixed Injection which is a product containing Esmolol Hydrochloride and sodium chloride. It is a sterile and nonpyrogenic solution that is for single intravenous use only. The usual dosage should be checked from the package insert. The solution should be clear colorless to light-yellow. The container should be checked for leaks before using the solution, and it should be discarded if leakage is found. The solution must not be used in series connections. The medication is manufactured by Intravia Container, a subsidiary of Baxter.*
Representative Carton Label 10019-670-10 (Image 04)
This is a product description for Brevibloc Premixed Injection - Esmolol Hydrochloride in Sodium Chloride. The product comes in 10 250 mL single-use Intravia containers, each containing 2,500 mg/250 mL (10 mg/m). It has to be stored at 25°C (77°F) and protected from freezing. The barcode needs to be placed by the manufacturer. The provided NDC is 10019-670-10.*
Representative Brevibloc 20mg Premier Pro Container Label 10019-666-10 (Image 05)
This is a description of a medication called Brevibloc manufactured by Baxter in the USA. It is a premixed double-strength injection containing 2,000 mg/100 mL of Esmolol Hydrochloride in Sodium Chloride. It is for single intravenous use only and contains no preservatives. The acidity of the solution is pH 5.0. The container should be checked for leaks before use, and if any leaks are found, the container should be discarded. Only use the medication if the solution is clear and colorless to light yellow. It should not be stored at temperatures below freezing and should not be used in series connections. The dosage details are not available in the text provided.*
Representative Container Label Ndc 10019-666-10 (Image 06)
The text describes BREVIBLOC PREMIXED injection solution contained separately in 10 100 mL single-use INTRAVIA containers. Each container holds Esmolol Hydrochloride In Sodium Chloride 2,000 mg/100 mL with double strength. It must be stored at temperatures ranging from 10-30°C. The manufacturer is Baxter Healthcare Corporation, and the containers have a unique identification code NDC 10019-666-10. The barcode placement is necessary.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.